Beryl Drugs Limited announced earnings results for the fourth quarter ended March 31, 2020. For the fourth quarter, the company announced total revenue was INR 31.099 million compared to INR 24.094 million a year ago. Net loss was INR 5.216 million compared to net income of INR 1.035 million a year ago. Basic loss per share was INR 1.03 compared to basic earnings per share of INR 0.2 a year ago. For the full year, total revenue was INR 130.482 million compared to INR 132.036 million a year ago. Net income was INR 479,000 compared to INR 5.907 million a year ago. Basic earnings per share was INR 0.09 compared to INR 1.16 a year ago.